Literature DB >> 4155438

Hepatic microsomal drug oxidation and electron transport in newborn infants.

J V Aranda, S M MacLeod, K W Renton, N R Eade.   

Abstract

Many drugs require oxidative metabolism for termination of action and/or for elimination from the body. Many oxidative reactions are catalyzed by hepatic microsomal enzymes. The activities of various drug-metabolizing enzymes, namely, NADPH cytochrome c reductase, NADPH oxidase, aminopyrine-N-demethylase, and analine P-hydroxylase, and the content of cytochrome P-450, were measured in hepatic microsomes obtained from seven newborn infants and four adult patients. The results in the newborn infant show increasing activities of these enzymes (except aminopyrine-N-demethylase) related to advancing age. Good correlation between three components of the hepatic microsomal mixed function oxidase system and aniline p-hydroxylase was established, whereas only NADPH oxidation correlated with aminopyrine N-demethylation. The rate of substrate or drug oxidation and the activities of the components of the microsomal electron transport pathway were lower than comparable values in the adult. The data demonstrate a possible biochemical basis for the transient deficiency in drug metabolism seen in newborn infants.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4155438     DOI: 10.1016/s0022-3476(74)80465-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  Chronic Intermittent Hypoxia Causes Lipid Peroxidation and Altered Phase 1 Drug Metabolizing Enzymes in the Neonatal Rat Liver.

Authors:  Charles Cai; Jacob V Aranda; Gloria B Valencia; Jiliu Xu; Kay D Beharry
Journal:  React Oxyg Species (Apex)       Date:  2017-05-01

2.  Neonatal Intermittent Hypoxia, Reactive Oxygen Species, and Oxygen-Induced Retinopathy.

Authors:  Kay D Beharry; Charles L Cai; Gloria B Valencia; Arwin M Valencia; Douglas R Lazzaro; Fayez Bany-Mohammed; Jacob V Aranda
Journal:  React Oxyg Species (Apex)       Date:  2017-01

Review 3.  Clinical pharmacology of the perinatal period and early infancy.

Authors:  P L Morselli
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

4.  Maturation of caffeine elimination in infancy.

Authors:  J V Aranda; J M Collinge; R Zinman; G Watters
Journal:  Arch Dis Child       Date:  1979-12       Impact factor: 3.791

5.  Pharmacokinetics of midazolam in critically ill neonates.

Authors:  E Jacqz-Aigrain; C Wood; I Robieux
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 6.  Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients.

Authors:  B J Anderson; A D McKee; N H Holford
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

7.  Development of N-demethylase activity measured with the 13C-aminopyrine breath test.

Authors:  E Jäger-Roman; D Rating; T Platzek; H Helge
Journal:  Eur J Pediatr       Date:  1982-10       Impact factor: 3.183

Review 8.  Pharmacokinetics of anti-infective agents in paediatric patients.

Authors:  D R Butler; R J Kuhn; M H Chandler
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

9.  Pharmacokinetics of nafcillin in infants with low birth weights.

Authors:  W Banner; W M Gooch; G Burckart; S B Korones
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

Review 10.  Disposition of antineoplastic agents in the very young child.

Authors:  H L McLeod; M V Relling; W R Crom; K Silverstein; S Groom; J H Rodman; G K Rivera; W M Crist; W E Evans
Journal:  Br J Cancer Suppl       Date:  1992-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.